- Report
- February 2024
- 288 Pages
Global
From €7029EUR$7,950USD£6,068GBP
- Report
- April 2023
- 115 Pages
Global
From €4200EUR$4,750USD£3,626GBP
- Report
- August 2022
- 110 Pages
Global
From €4200EUR$4,750USD£3,626GBP
- Report
- February 2024
- 115 Pages
Global
From €4200EUR$4,750USD£3,626GBP
- Report
- January 2024
- 200 Pages
Global
From €3669EUR$4,150USD£3,168GBP
- Report
- July 2024
- 147 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- November 2023
- 150 Pages
Global
From €3934EUR$4,450USD£3,397GBP
- Report
- April 2023
- 150 Pages
Global
From €3404EUR$3,850USD£2,939GBP
€4288EUR$4,850USD£3,702GBP
- Report
- August 2022
- 113 Pages
Global
From €3979EUR$4,500USD£3,435GBP
- Report
- July 2023
- 140 Pages
Global
From €4376EUR$4,949USD£3,778GBP
- Report
- May 2023
- 147 Pages
Global
From €4376EUR$4,949USD£3,778GBP
- Report
- November 2023
- 309 Pages
Global
€4416EUR$4,995USD£3,813GBP
- Report
- April 2023
- 147 Pages
Global
From €4376EUR$4,949USD£3,778GBP
- Report
- April 2023
- 147 Pages
Global
From €4376EUR$4,949USD£3,778GBP
- Report
- June 2022
- 300 Pages
Global
From €3183EUR$3,600USD£2,748GBP
- Report
- January 2024
- 200 Pages
Global
From €3669EUR$4,150USD£3,168GBP
- Report
- September 2024
- 144 Pages
China
From €1591EUR$1,800USD£1,374GBP
- Report
- April 2023
- 91 Pages
Global
From €3500EUR$4,241USD£3,127GBP
- Report
- October 2024
- 101 Pages
Global
From €3500EUR$4,241USD£3,127GBP
- Report
- February 2024
- 95 Pages
Global
From €3500EUR$4,241USD£3,127GBP

The Human Albumin market is a subset of the biotechnology industry that focuses on the production and sale of human albumin, a protein found in human blood plasma. Human albumin is used in a variety of medical treatments, including the treatment of shock, burns, and other trauma-related conditions. It is also used in the production of a variety of pharmaceuticals, including vaccines and drugs.
The Human Albumin market is highly regulated, with strict standards for quality and safety. Companies in the market must adhere to stringent regulations and guidelines set by the US Food and Drug Administration (FDA) and other regulatory bodies.
The Human Albumin market is highly competitive, with a number of companies competing for market share. Companies in the market include CSL Behring, Grifols, Octapharma, Kedrion, and Biotest. Show Less Read more